Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ruttala, Hima Bindu | - |
dc.contributor.author | Ramasamy, Thiruganesh | - |
dc.contributor.author | Madeshwaran, Thiagarajan | - |
dc.contributor.author | Tran Tuan Hiep | - |
dc.contributor.author | Kandasamy, Umadevi | - |
dc.contributor.author | Oh, Kyung Taek | - |
dc.contributor.author | Choi, Han-Gon | - |
dc.contributor.author | Yong, Chul Soon | - |
dc.contributor.author | Kim, Jong Oh | - |
dc.date.available | 2019-01-22T14:13:10Z | - |
dc.date.issued | 2018-02 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.issn | 1976-3786 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/1238 | - |
dc.description.abstract | The development of novel drug delivery systems based on well-defined polymer therapeutics has led to significant improvements in the treatment of multiple disorders. Advances in material chemistry, nanotechnology, and nanomedicine have revolutionized the practices of drug delivery. Stimulus-responsive material-based nanosized drug delivery systems have remarkable properties that allow them to circumvent biological barriers and achieve targeted intracellular drug delivery. Specifically, the development of novel nanocarrier-based therapeutics is the need of the hour in managing complex diseases. In this review, we have briefly described the fundamentals of drug targeting to diseased tissues, physiological barriers in the human body, and the mechanisms/modes of drug-loaded carrier systems. To that end, this review serves as a comprehensive overview of the recent developments in stimulus-responsive drug delivery systems, with focus on their potential applications and impact on the future of drug delivery. | - |
dc.format.extent | 19 | - |
dc.publisher | PHARMACEUTICAL SOC KOREA | - |
dc.title | Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s12272-017-0995-x | - |
dc.identifier.bibliographicCitation | ARCHIVES OF PHARMACAL RESEARCH, v.41, no.2, pp 111 - 129 | - |
dc.identifier.kciid | ART002315644 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000424689700001 | - |
dc.identifier.scopusid | 2-s2.0-85037174830 | - |
dc.citation.endPage | 129 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 111 | - |
dc.citation.title | ARCHIVES OF PHARMACAL RESEARCH | - |
dc.citation.volume | 41 | - |
dc.type.docType | Review | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Nanomedicine | - |
dc.subject.keywordAuthor | Polymer therapeutics | - |
dc.subject.keywordAuthor | Drug delivery systems | - |
dc.subject.keywordAuthor | Stimulus-responsive | - |
dc.subject.keywordPlus | MESOPOROUS SILICA NANOPARTICLES | - |
dc.subject.keywordPlus | INTRACELLULAR-CONTROLLED-RELEASE | - |
dc.subject.keywordPlus | POLYELECTROLYTE COMPLEX MICELLES | - |
dc.subject.keywordPlus | COPOLYMER AQUEOUS-SOLUTIONS | - |
dc.subject.keywordPlus | CANCER COMBINATION THERAPY | - |
dc.subject.keywordPlus | TARGETED GENE DELIVERY | - |
dc.subject.keywordPlus | IN-VIVO EVALUATION | - |
dc.subject.keywordPlus | CO-DELIVERY | - |
dc.subject.keywordPlus | BREAST-CANCER | - |
dc.subject.keywordPlus | POLYMERIC MICELLES | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.